10-K Decoder · All companies

Kymera Therapeutics, Inc.

KYMR · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$39.2M$47.1M−16.7%
Operating income−$349M−$262M−33.5%
Net income−$311M−$224M−39.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026

$Q3 2026Year earlierChange
Revenue$0K$2.80M−100%
Operating income−$147M−$92.5M−59.1%
Net income−$132M−$82.2M−60.6%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Kymera's revenue in FY2025?
$39.2M in FY2025 (Fiscal year ended Dec 31, 2025), −16.7% vs $47.1M a year earlier, per its 10-K filed Feb 2026.
Was Kymera profitable in FY2025?
No: net income was −$311M and operating income −$349M in FY2025.
What was Kymera's revenue in Q3 2026?
$0K (−100% vs a year earlier), per its Form 10-Q filed Oct 29, 2026.